Analysts: Perrigo Has a Better Earnings Outlook and 3 More Research Notes to Read Over
Perrigo (NASDAQ:PRGO): Deutsche Bank has upgraded Perrigo to Buy from Hold, citing yesterday’s pullback in shares and a better earnings outlook following the acquisition of Elan (NYSE:ELN). Deutsche also raised its price target for shares to $150 from $120.
Depomed (NASDAQ:DEPO): JMP Securities believes that Depomed’s acquisition of rights to Lazanda, a nasal spray for cancer pain management, is a good strategic fit for the company and thinks that Depomed can realize a meaningfully positive return on investment from the deal. JMP reiterates an Outperform rating on the stock.
Qihoo 360 (NYSE:QIHU): Maxim has raised its price target for Qihoo 360 to $72 from $48, citing the company’s earnings growth potential and a good chance of success for an acquisition of Sogou. The firm keeps a Buy rating on the stock.
SunPower (NASDAQ:SPWR): RW Baird raised its price target on SunPower to $33 from $24 to better reflect higher-than-expected ASPs, strong demand in Japan, and solid demand across all customer classes in the U.S. The shares are Outperform rated.